updated results of the bruin trial: pirtobrutinib in r/r mcl
Published 11 months ago • 175 plays • Length 0:55Download video MP4
Download video MP3
Similar videos
-
1:59
updated results from the bruin study: pirtobrutinib in the treatment of mcl
-
1:56
updated results of phase i/ii bruin study: pirtobrutinib in covalent btk inhibitor pretreated mcl
-
3:01
updates from the bruin study – long-term safety of pirtobrutinib in r/r mcl
-
1:35
pirtobrutinib in r/r fl: results from the bruin study
-
1:06
pirtobrutinib in r/r mzl: insights from the bruin trial
-
1:32
genomic evolution & resistance to pirtobrutinib in covalent btk inhibitor pre-treated cll
-
1:55
update on the phase i/ii bruin study
-
2:49
results from the phase iii echo trial of acalabrutinib plus br in mcl
-
4:35
updated safety & efficacy data from manifest-2: pelabresib plus ruxolitinib for myelofibrosis
-
6:05
updates in pv treatment: the efficacy of ropeginterferon alfa-2b
-
2:21
mezigdomide: a novel celmod showing promise in the treatment of r/r myeloma
-
1:17
keynote-667: pembrolizumab plus copdac-28 for high-risk chl with slow early response to oepa
-
2:25
results from a phase i/ii trial of pirtobrutinib and lv20.19 for patients with r/r lymphomas
-
1:30
the use of pirtobrutinib in richter's transformation: data from the bruin trial
-
1:43
extended follow-up of the alpine trial: superior outcomes with zanubrutinib in r/r cll/sll
-
1:59
the optec study: evaluating outpatient step-up administration of teclistamab in pts with r/r myeloma
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
2:14
ongoing trials investigating the efficacy of pirtobrutinib in cll
-
1:22
long-term follow-up results of tourmaline-mm2: ird vs pbo-rd in multiple myeloma
-
3:01
updated results from epcore nhl-2: epcoritamab plus gemox in patients with r/r dlbcl
-
1:32
novel btki strategies in indolent b-cell malignancies: pirtobrutinib for fl and mzl
-
2:14
long-term follow-up results from the rathl trial: response-adapted treatment for advanced stage hl